+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Healthcare Licensing Trends: Scandinavia-Non-Listed

  • ID: 4861668
  • Report
  • September 2019
  • Region: Global
  • 66 pages
  • FinGlobe, Inc

FEATURED COMPANIES

  • ADDvise Group AB
  • Cartana AB
  • Genagon Therapeutics AB
  • Lokon Pharma AB
  • Oncoinvent AS
  • Sedana Medical AB
  • MORE
This trends report provides comprehensive analysis on all licensing deals and negotiations reported for the Non-Listed healthcare companies of Scandinavia during January 1, 2019 to August 31, 2019, categorized and summarized by various important aspects such as healthcare sub-sectors, medicine groups, across key regions, licensing payment arrangements, and worldwide vs domestic licensing. Such detailed analysis helps to understand the licensing trends and directions during this time period in the healthcare segment of Scandinavia Non-Listed sector.

Analytical data coverage:
  • January 1, 2019 to August 31, 2019 licensing deals and negotiations
  • 80+ healthcare licensing news for Scandinavian Non-Listed healthcare companies (60+)
  • 4 healthcare sub-sectors covered-Pharmaceuticals (39%), Biotech (26%), Medical Devices (30%), Healthcare Services (5%)
  • Non-Listed companies included (click here to view a list of companies covered)
  • 14 medicine groups studied-Oncology (21%), Dermatology and Infectious Disease (13% each)
  • 8+ variables analyzed
Key Features:
  • 8 months’ healthcare licensing transactions of Scandinavia (Non-Listed) analyzed at one place
  • Curated categorizations of licensing details
  • Licensing trends and directions summarized
The Report is useful to:
  • Scandinavian Non-Listed companies planning to introduce products in other countries
  • Companies active in R&D and seeking new market base
  • Healthcare company executives of Scandinavia (Non-Listed) sector negotiating licensing deals
  • Investors analyzing varied kinds of transaction options for licensing deals in Scandinavia (Non-Listed) sector
Key analysis provided: January-August 2019
  • Total number of licensing deals signed by Non-Listed companies of Scandinavia
  • Total number of Non-Listed companies of Scandinavia involved in the licensing deals
  • Most licensing deals signed by which of the Scandinavian countries
  • Most licensing deals signed by which sub-industry within healthcare sector
  • Most licensing deals signed by which medicine groups
  • Licensing payment arrangements most followed in the licensing deals
  • Number of domestic and worldwide licensing
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ADDvise Group AB
  • Cartana AB
  • Genagon Therapeutics AB
  • Lokon Pharma AB
  • Oncoinvent AS
  • Sedana Medical AB
  • MORE
Introduction
Research Design

Chapter 1: Analysis of healthcare inventions of Scandinavia (Non-Listed) licensed during last eight months
1.1 Countries with most licensing deals
1.2 Healthcare sub-sectors with most licensing deals
1.3 Medicine groups most active in licensing deals
1.4 Licensing payment arrangements most followed
1.5 Worldwide licensing vs domestic licensing

Chapter 2: Analysis of licensing deals of Scandinavia (Non-Listed) by key attributes during last eight months
2.1 For each of the countries
2.2 For each of the healthcare sub-sectors
2.3 For each of the medicine groups
2.4 Across each of the regions

Chapter 3: Summary and conclusions

Appendices
Appendix 1 Healthcare inventions licensed for Scandinavia (Non-Listed) during last eight months - By company name
Appendix 2 List of companies/institutes covered - By country and company name
Appendix 3 List of companies/institutes covered - By sub-industry and company name
Appendix 4 List of companies/institutes covered - By medicine group and company name
Appendix 5 List of companies/institutes covered - By terms of payment and company name
Appendix 6 Licensing deals discontinued for Scandinavia (Non-Listed) during last eight months
Note: Product cover images may vary from those shown
  • ADDvise Group AB
  • Affibody AB
  • Anthrop Pharmaceuticals AB
  • Apoteket AB
  • ArcDia International Oy Ltd.
  • Attana AB
  • Bactiguard AB
  • Beactica AB
  • Belina Pharma AB
  • Bioneer A/S
  • BoneSupport AB
  • Cartana AB
  • CBD Solutions AB
  • CCS Healthcare AB
  • COBO Technologies Aps
  • Coloplast A/S
  • Diaverum AB
  • Ecobrands AS
  • Elekta Instrument AB
  • Emeriti Bio AB
  • Genagon Therapeutics AB
  • Gubra
  • Heart2Save Oy
  • Herantis Pharma Plc
  • Immuno Diagnostic Oy
  • Inhalation Sciences Sweden AB
  • Invent Medic Sweden AB
  • Kappa Bioscience AS
  • LEO Pharma A/S
  • Lipum AB
  • Lokon Pharma AB
  • Mobidiag Ltd.
  • Molnlycke Health Care AB
  • Nanologica AB
  • NattoPharma ASA
  • Nightingale Health Ltd
  • Nordic Bioscience A/S
  • Novo Nordisk Pharmatech A/S
  • ObsteCare AB
  • OncoImmunity AS
  • Oncoinvent AS
  • Perimed AB
  • Pilloxa AB
  • Planmeca Oy
  • POA Pharma Scandinavia AB
  • Promimic AB
  • Radiometer Medical ApS
  • Sandoz Nordics
  • Schroll Medical ApS
  • Sedana Medical AB
  • Serca Pharmaceuticals AS
  • Solural Pharma ApS
  • SyntheticMR AB
  • Tataa Biocenter AB
  • Teva Sweden AB
  • TILT Biotherapeutics Ltd
  • Trimb Healthcare AB
  • VibroSense Dynamics AB
  • Vingmed Holding A/S
  • Xellia Pharmaceuticals ApS
  • Zelluna Immunotherapy AS
Note: Product cover images may vary from those shown
Adroll
adroll